Pentobarbital Sodium

CHEMBL971 Phase 4 Approved Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
248.2 g/mol
LogP
—
Phase
4

A sodium salt form of pentobarbital with the same therapeutic properties. This barbiturate treats severe seizures and is used for sedation before surgery.

Molecular Weight

248.2500 g/mol

TPSA

81.60 Ų

Therapeutic Areas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCC(C)C1(CC)C(=O)N=C([O-])NC1=O.[Na+]

InChI

InChI=1S/C11H18N2O3.Na/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15;/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16);/q;+1/p-1

Molecular Formula

C11H17N2NaO3

HBD / HBA

1 / 3

Rotatable Bonds

4

Heavy Atoms

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A sodium salt form of pentobarbital with the same therapeutic properties. This barbiturate treats severe seizures and is used for sedation before surgery.

Yes, Pentobarbital Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL971. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23676152. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.